News archive
GLP‑1 news from 2000
2 dated, sourced GLP-1 developments from 2000: approvals, trial results, prices, lawsuits, compounding and culture.
- Business
A federal appeals court strips Prozac of patent protection two years early
Lilly shares fell about a third in the days that followed, beginning an eight-year slide that bottomed at $29 in 2008. The episode still shapes how Lilly plans around patent expirations.
- Business
Novozymes spun out of Novo Nordisk
Novo Nordisk spun off its enzymes business as Novozymes, later Novonesis. Both remain under the control of the Novo Nordisk Foundation through Novo Holdings.